As a senior researcher at the Synthetic Biology and Precision Medicine Centre, Council for Scientific and Industrial Research (CSIR), South Africa, Dr Takundwa has worked for the past 3 years together with the team and collaborators in state academic hospitals to establish a cancer precision medicine platform in South Africa. She is an alumnus of the University of Namibia and conducted postdoctoral research at the North-west University-Mafikeng and the University of Cape Town. Her current research interests are focused in Gynaecological cancers where she explores drug sensitivity for drug repurposing and genomics using of patient-derived models to unravel unique characteristics of the African patient cohorts. The group is leveraging new approaches to repurpose drugs for cancer personalized medicine together with next generation sequencing technologies. She promotes STEMI through to the African Cancer Leaders Institute, Black Women in Science-SA Chapter, AACR GSITA and various advisory panels. She holds honorary appointments with the University of Pretoria and Rhodes University. she has previously worked for the pharmaceutical giant Roche and during COVID helped establish a PCR testing lab serving the Western Cape Government and rural provinces of South Africa.